<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Background- Substrate abnormality in pulmonary vein (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e>) antrum plays a critical role in mechanism of <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> (AF) </plain></SENT>
<SENT sid="1" pm="."><plain>The present study compares the strategy of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e> antrum radial-linear (PAR) ablation to encircling <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e> isolation for paroxysmal AF </plain></SENT>
<SENT sid="2" pm="."><plain>Methods and Results- A total of 86 patients with paroxysmal AF were randomly assigned to PAR ablation group or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e> isolation group </plain></SENT>
<SENT sid="3" pm="."><plain>The average procedure time was 161±21 minutes in PAR ablation group and 199±39 minutes in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e> isolation group (P&lt;0.01) </plain></SENT>
<SENT sid="4" pm="."><plain>The average fluoroscopy time was 25±5 minutes in PAR ablation group and 32±9 minutes in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e> isolation group (P&lt;0.001) </plain></SENT>
<SENT sid="5" pm="."><plain>At 14 (15-12) months of follow-up after single procedure, 31 of 42 (74%) patients in PAR ablation group and 22 of 44 patients (50%) in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e> isolation group had no recurrence of AF off antiarrhythmic drug (P=0.0249); and 36 of 42 patients (86%) in PAR ablation group and 26 of 44 patients (59%) in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e> isolation group had no recurrence of AF with antiarrhythmic drug (P=0.006) </plain></SENT>
<SENT sid="6" pm="."><plain>In addition, PAR ablation resulted in greater reduction of left atrial diameter than encircling <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e> isolation </plain></SENT>
<SENT sid="7" pm="."><plain>Multivariable Cox regression analysis showed that only ablation strategy was independently associated with AF recurrence (hazard ratio, 0.31; 95% confidence interval, 0.12-0.78; P=0.013) </plain></SENT>
<SENT sid="8" pm="."><plain>No major adverse event related to the procedures occurred </plain></SENT>
<SENT sid="9" pm="."><plain>Conclusions- This study suggests that PAR ablation is a potentially effective strategy for treatment of paroxysmal AF warranting further investigation </plain></SENT>
<SENT sid="10" pm="."><plain>Clinical Trial Registration- URL: http://www.chictr.org; Unique identifier: ChiCTR-TRC-11001191 </plain></SENT>
</text></document>